Literature DB >> 18054815

Adrenomedullin is increased by pulsatile shear stress on the vascular endothelium via periodic acceleration (pGz).

Alfredo Martínez1, Jaqueline Arias, Jorge A Bassuk, Heng Wu, Paul Kurlansky, Jose A Adams.   

Abstract

Periodic acceleration (pGz) is produced by a platform which moves the supine body repetitively in a headward to footward direction. The imparted motion produces pulsatile shear stress on the vascular endothelium. Pulsatile shear stress on the vascular endothelium has been shown to elicit production of a host of cardioprotective, cytoprotective mediators. The purpose of this study was to ascertain if pGz also enhances production of adrenomedullin (AM) in normal healthy swine. Twelve pigs (weight range 20-30 kg) were anesthetized, intubated and placed on conventional mechanical ventilation. All animals were secured to the motion platform. In one group (pGz) (n=7) was activated for 1h, and monitored for an additional 3h. A control group (CONT) (n=5) served as time control. Arterial blood gases, hemodynamic measurements, and serum for AM, interleukin 4, 6 and thromboxane B(2) (TBXB2) were measured at baseline, immediately after pGz, and 3h after pGz had been discontinued. There was no significant change from baseline value in IL-4, IL-6 or TBXB2. Mean arterial blood pressure decreased in pGz-treated animals from 115+/-10 at baseline to 90+/-8 after 60 min of pGz (p<0.01). AM levels increase from 776+/-176 pg/ml baseline to 1160+/-68 pg/ml immediately after pGz, and remained elevated to 1584+/-160 pg/ml, 3h after pGz (p<0.01 vs. BL). This is the first report of AM-enhanced production using a non-invasive method of increasing pulsatile shear stress on the vascular endothelium. pGz increases production of AM in normal healthy swine. These changes are independent of IL-4, IL-6 or TBXB2 production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054815     DOI: 10.1016/j.peptides.2007.10.021

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.

Authors:  Andras Iring; Young-June Jin; Julián Albarrán-Juárez; Mauro Siragusa; ShengPeng Wang; Péter T Dancs; Akiko Nakayama; Sarah Tonack; Min Chen; Carsten Künne; Anna M Sokol; Stefan Günther; Alfredo Martínez; Ingrid Fleming; Nina Wettschureck; Johannes Graumann; Lee S Weinstein; Stefan Offermanns
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

2.  Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).

Authors:  Arkady Uryash; Jorge Bassuk; Paul Kurlansky; Francisco Altamirano; Jose R Lopez; Jose A Adams
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

3.  Disturbed flow-induced Gs-mediated signaling protects against endothelial inflammation and atherosclerosis.

Authors:  Akiko Nakayama; Julián Albarrán-Juárez; Guozheng Liang; Kenneth Anthony Roquid; András Iring; Sarah Tonack; Min Chen; Oliver J Müller; Lee S Weinstein; Stefan Offermanns
Journal:  JCI Insight       Date:  2020-12-03

Review 4.  Possible Mechanisms for the Effects of Sound Vibration on Human Health.

Authors:  Lee Bartel; Abdullah Mosabbir
Journal:  Healthcare (Basel)       Date:  2021-05-18

5.  Changes of blood pressure following initiation of physical inactivity and after external addition of pulses to circulation.

Authors:  Marvin A Sackner; Shivam Patel; Jose A Adams
Journal:  Eur J Appl Physiol       Date:  2018-10-22       Impact factor: 3.078

6.  Whole body periodic acceleration improves survival and microvascular leak in a murine endotoxin model.

Authors:  Jose A Adams; Arkady Uryash; Jose R Lopez; Marvin A Sackner
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

7.  Endothelial pulsatile shear stress is a backstop for COVID-19.

Authors:  Marvin A Sackner; Jose A Adams
Journal:  Emerg Top Life Sci       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.